CNC Centene Corporation Common Stock
$65,06
Cena · Sie 19, 2026
Dane fundamentalne na dzień Lip 28, 2026
Zakres 52 tyg.
$28–$69
90% of range
Ocena Analityków
HOLD
27 analysts
Cena Docelowa
$72
+10% upside
P/E (TTM)
-6.1
ROE
-28.8%
Marża Zysku Netto
-3.4%
O Centene Corporation Common Stock Przegląd firmy z Wikipedii
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
Czytaj więcej
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500.
History
Centene was founded by Elizabeth Brinn as Managed Health Services in Milwaukee, Wisconsin, in 1984. After the death of Brinn, the non-profit organization was sold to investors. The proceeds went to the Betty Brinn Foundation, which became a major shareholder in Centene. In 1996, Michael Neidorff joined the company as chief executive.
Centene went public in December 2001. In 2006, the firm acquired US Script, a pharmacy benefits manager. The company later merged US Script with subsidiaries to form its Envolve divisions. In 2011, the firm formed Centurion, a provider of correctional health care services, as a joint venture with MHM Services. In 2018, it acquired MHM Services, including its stake in Centurion. Centene began offering state-run Medicaid programs through Affordable Care Act exchanges in 2014.
In July 2015, Centene announced it would acquire Health Net and Trillium Community Health Plan (serving Oregon). In March 2016, it finalized its acquisition. In September 2017, it announced that it would acquire Fidelis Care, a nonprofit insurer in New York, for US$3.75 billion. In March 2019, it announced plans to acquire WellCare for US$17.3 billion. In January 2021, it was announced that it would acquire Magellan Health for $2.2 billion. In January 2022, the acquisition was completed.
In the United Kingdom, Centene began to acquire local healthcare services in 2017. In 2019, Centene, through its subsidiary MH Services, took a 40% stake in Circle Health, as part of a deal which created a national network of over 50 private hospitals. Centene gained full control of Circle Health in July 2021, and sold the business to PureHealth in August 2023.
In early 2021, Operose Health, a UK subsidiary of Centene, took over a group of London practices, AT Medics.
In May 2022, Centene sold off its pharmacy benefit management businesses, Magellan Rx and PANTHERx Rare, for a total of $2.8 billion.
Business segments
The main lines of Centene include:
Medicaid
Arizona Complete Health
Arkansas Total Care
Health Net (California)
Delaware First Health
Sunshine Health (Florida)
Peach State Health Plan (Georgia)
'Ohana Health Plan (Hawaii)
Meridian (Illinois and Michigan)
Managed Health Care Services (Indiana)
Iowa Total Care
Sunflower Health Plan (Kansas)
WellCare of Kentucky
Louisiana Healthcare Connections
Magnolia Health (Mississippi)
Home State Health Plan (Missouri)
Nebraska Total Care
SilverSummit Healthplan (Nevada)
NH Healthy Families (New Hampshire)
Fidelis Care (New Jersey, New York)
Carolina Complete Health (North Carolina)
WellCare of North Carolina
Buckeye Health Plan (Ohio)
Oklahoma Complete Health
Trillium Community Health Plan (Oregon)
PA Health & Wellness (Pennsylvania)
Absolute Total Care (South Carolina)
Superior HealthPlan (Texas)
Coordinated Care (Washington)
MHS Health Wisconsin
ACA health insurance marketplace - Ambetter
Arkansas Health & Wellness
Celtic Insurance Company
WellCare of New Jersey
Medicare
WellCare
Allwell
Correctional healthcare - Centurion
Commercial insurance
QualChoice (Arkansas)
Health Net (California, Oregon)
Behavioral health - Magellan Health
Leaders
In 2020, CEO Michael Neidorff's compensation of nearly $25 million made him the highest-paid healthcare executive in the United States.
In December 2021, Politan Capital Management took a $900 million stake in Centene. Weeks later, Neidorff announced plans to retire within a year. He actually stepped down in March 2022.
He was replaced by Sarah London.
Controversies
In 2014, Fox News alleged that Superior HealthPlan of Texas denied coverage of an infant's surgery for brain cancer at Texas Children's Hospital. Superior HealthPlan is a joint venture of Centene and Community Health Centers Network LP, which provides services for Medicaid recipients. The article reported that Superior HealthPlan had previously paid healthcare claims for the infant at the hospital, although Superior HealthPlan stated that it did not cover procedures at the facility. Three days after the article was published, Superior HealthPlan reversed its decision and covered the surgery.
In January 2018, a class action lawsuit accused Centene's Ambetter marketplace healthcare plans of misleading enrollees about plan benefits. According to the lawsuit, people who bought Centene's plans had difficulty finding medical providers that accepted patients covered under Centene's policies.
In December 2018, Centene was sued by two pension funds alleging that Centene's acquisition of Health Net resulted in damages to Centene and exposed the company to potential liability. The suit also alleged that Centene concealed that Health Net owed approximately $1B in past tax liabilities to California and was under investigation for Medicare fraud at the time of the acquisition.
In 2022, Operose Health had almost 600,000 NHS patients and was the largest supplier of GP services to the NHS. It was accused of putting patients at risk by prioritising profit, specifically by hiring physician associates, because they were cheaper than GPs. At Operose practices the average number of full time equivalent GPs per patients is about half the average in English practices. Sir Sam Everington said he was worried to see physician associates saying they were not receiving the supervision they needed. The practice had a backlog of thousands of medical test results and hospital letters on their computer systems. Operose said 97% of its practices were rated "good" or "outstanding" by the Care Quality Commission.
In April of 2026, Centene Corporation reportedly ended coverage of hormone replacement therapy for transgender patients in its Ambetter Insurance medicare and medicaid plans across 19 states without informing customers.
Settlements
In April 2021, Health Net Federal Services, a subsidiary of Centene, agreed to pay $97M to settle allegations that it had duplicated or inflated claims submitted to the Department of Veterans Affairs.
Between June 2021 and January 2022, Centene agreed to settlements with several states on behalf of their subsidiary, Envolve, a pharmacy benefit manager, including Ohio, Mississippi, Illinois, Arkansas, and New Hampshire to resolve allegations of overpayments to the PBM from the states' Medicaid programs. The settlements have totaled over $191 million.
In December 2021, Centene agreed to pay $27.6M to Kansas to settle allegations that it had failed to disclose discounts and used other strategies to obtain more profit from Kansas' Medicaid program.
In September 2022, Centene will pay more than $14 million to Massachusetts's to resolve claims that it overcharged the state Medicaid program, MassHealth, millions of dollars for pharmacy benefits and services provided by subsidiary companies.
Centene overbilled Florida $67 million in 2021 and proactively notified the state. Their discussions with Agency for Health Care Administration (AHCA) ended in 2024 and Centene agreed to return the $67 million. $10 million of that was sent to Hope Florida Foundation, rather than the state directly.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
CNC Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$65.06
Kapitalizacja Rynkowa
$40.69B
P/E (TTM)
-6.1
EPS (TTM)
$-13.53
Przychody (TTM)
$194.78B
Stopa dywidendy
—
ROE
-28.8%
D/E Dług/Kapitał
0.9
Zakres 52 tyg.
$28 – $69
CNC Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$194.78B
2016-12-31
→
2025-12-31
EPS
$-13.53
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
$4.32B
2016-12-31
→
2025-12-31
Marże
-3.4%
2023-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CNC
Mediana porównawcza
P/E (TTM)
-6.1
35.0
P/S (TTM)
0.2
0.9
P/B
2.0
3.5
EV / EBITDA
-5.0
—
Price / FCF (Cena / FCF)
9.4
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CNC
Mediana porównawcza
Gross Margin (Marża brutto)
7.3%
12.9%
Operating Margin (Marża Operacyjna)
-3.9%
—
Net Profit Margin (Marża Zysku Netto)
-3.4%
0.89%
ROA
-8.4%
3.5%
ROE
-28.8%
10.1%
ROIC
-20.2%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CNC
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.9
—
Current Ratio (Wskaźnik bieżący)
1.1
1.6
Quick Ratio (Wskaźnik Szybkości)
0.6
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CNC
Mediana porównawcza
Revenue YoY (Przychody R/R)
19.4%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
10.4%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
11.9%
—
EPS YoY
27.5%
—
Net Income YoY (Zysk Netto R/R)
22.3%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CNC
Mediana porównawcza
CNC Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
27 analityków
- Mocne kupno 4 14,8%
- Kup 7 25,9%
- Trzymaj 15 55,6%
- Sprzedaj 1 3,7%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
18 analityków · 2026-08-13
Mediana
$70.50
Teraz
$65.06
Niski
$56.00
Wysoki
$85.00
Średni cel
$70.50
+8,4%
Średnia cel
$71.67
+10,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.44%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $2.51 | $1.10 | 1.4% |
| 31 marca 2026 | $3.37 | $2.15 | 1.2% |
| 31 grudnia 2025 | $-1.19 | $-1.24 | 0.05% |
| 30 września 2025 | $0.50 | $-0.14 | 0.64% |
| 30 czerwca 2025 | $-0.16 | $0.87 | -1.0% |
| 31 marca 2025 | $2.90 | $2.57 | 0.33% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Cost of Revenue | $2.67B | $2.73B | $3.56B | $7.03B | $4.89B | $3.30B | $2.46B | $2.39B | $1.85B | $1.86B | $1.62B | $1.28B | |
| Gross Profit | $14.21B | $17.07B | $17.64B | $16.92B | $14.49B | · | · | · | · | · | · | · | |
| SG&A Expense | $12.90B | $12.40B | $12.56B | $11.59B | $9.60B | $9.38B | $6.53B | $6.04B | $4.45B | $3.67B | $1.80B | $1.30B | |
| Operating Expenses | $202.40B | $159.90B | $151.07B | $143.23B | $124.20B | $108.03B | $72.86B | $58.66B | $47.18B | $39.34B | $22.05B | $16.10B | |
| Operating Income | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M | |
| Interest Expense | · | · | $725M | $665M | $665M | $728M | $412M | $343M | $255M | $217M | $43M | $35M | |
| Other Non-op | $895M | $1.08B | $668M | $644M | · | · | · | · | · | · | · | · | |
| Pretax Income | $-6.73B | $4.26B | $3.60B | $1.96B | $1.81B | $2.77B | $1.78B | $1.37B | $1.13B | $1.16B | $697M | $457M | |
| Income Tax | $-51M | $963M | $899M | $760M | $477M | $979M | $473M | $474M | $326M | $599M | $339M | $196M | |
| Net Income | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| EPS (Basic) | $-13.53 | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $3.19 | $2.31 | $2.40 | $1.76 | $2.98 | $2.33 | |
| EPS (Diluted) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 | $3.12 | $3.14 | $2.26 | $2.34 | $1.71 | $2.88 | $2.25 | |
| Shares (Basic) | 493,116,000 | 521,790,000 | 543,319,000 | 575,191,000 | 582,832,000 | 570,722,000 | 413,487,000 | 390,248,000 | 344,853,000 | 319,135,000 | 119,101,000 | 116,345,764 | |
| Shares (Diluted) | 493,116,000 | 523,744,000 | 545,704,000 | 582,040,000 | 590,516,000 | 579,135,000 | 420,409,000 | 398,506,000 | 353,404,000 | 327,951,000 | 123,066,000 | 120,360,212 | |
| EBITDA | $-7.62B | $3.17B | $2.93B | $1.32B | $1.78B | $3.08B | $1.78B | $1.46B | $1.20B | $1.26B | $705M | $464M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.89B | $14.06B | $17.19B | $12.07B | $13.12B | $10.80B | $12.12B | $5.34B | $4.07B | $3.93B | $1.76B | $1.61B | |
| Short-term Investments | $2.43B | $2.62B | $2.46B | $2.32B | $1.54B | $1.58B | $863M | $722M | $531M | $505M | $176M | $177M | |
| Other Current Assets | $1.95B | $1.60B | $5.57B | $2.46B | $1.60B | $1.32B | $1.09B | $784M | $687M | $715M | $390M | $252M | |
| Current Assets | $40.37B | $38.00B | $40.76B | $30.13B | $28.50B | $23.39B | $20.32B | $12.00B | $8.70B | $8.37B | $3.60B | $2.95B | |
| PP&E (Net) | $2.04B | $2.07B | $2.02B | $2.43B | $3.39B | $2.77B | $2.12B | $1.71B | $1.10B | $797M | $518M | $445M | |
| PP&E (Gross) | $4.27B | $4.87B | $4.42B | $4.50B | $5.29B | $4.25B | $3.22B | $2.51B | $1.69B | $1.24B | $869M | $733M | |
| Accum. Depreciation | $2.23B | $2.80B | $2.40B | $2.07B | $1.90B | $1.48B | $1.10B | $800M | $590M | $442M | $351M | $288M | |
| Goodwill | $10.84B | $17.56B | $17.56B | $18.81B | $19.77B | $18.65B | $6.86B | $7.01B | $4.75B | $4.71B | $842M | $754M | |
| Intangibles | $4.53B | $5.41B | $6.10B | $6.91B | $7.82B | $8.39B | $2.06B | $2.24B | $1.40B | $1.54B | $155M | $120M | |
| Other Non-current Assets | $528M | $593M | $535M | $2.69B | $3.78B | $1.60B | $1.25B | $527M | $454M | $95M | $177M | $174M | |
| Total Assets | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Accounts Payable | $13.80B | $13.17B | $16.42B | $9.53B | $8.49B | $7.07B | $4.16B | $4.05B | $4.17B | $3.76B | $976M | $768M | |
| Current Liabilities | $36.72B | $34.26B | $36.72B | $28.46B | $25.77B | $21.59B | $12.93B | $11.97B | $9.33B | $8.62B | $3.63B | $2.90B | |
| Capital Leases | $615M | $738M | $880M | $3.13B | $3.62B | $1.33B | $622M | · | · | · | · | · | |
| Deferred Tax | $833M | $684M | $641M | $615M | $1.41B | $1.53B | $189M | · | · | · | · | · | |
| Other Non-current Liabilities | $1.79B | $2.57B | $3.62B | $5.62B | $5.61B | $2.96B | $1.54B | $1.26B | $952M | $869M | $170M | $159M | |
| Total Liabilities | $56.69B | $55.94B | $58.69B | $52.63B | $51.35B | $42.76B | $28.30B | $19.88B | $14.98B | $14.14B | $5.01B | $3.93B | |
| Long-term Debt | $17.49B | $18.64B | $17.96B | $18.18B | $19.03B | $16.88B | $13.86B | $6.85B | $4.83B | $4.78B | $1.22B | $878M | |
| Total Debt | $17.40B | $18.53B | $17.83B | $18.02B | $18.84B | $16.78B | $13.73B | $6.69B | $4.70B | $4.66B | $1.22B | $893M | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $8.67B | $15.35B | $12.04B | $9.34B | $8.14B | $6.79B | $4.98B | $3.66B | $2.75B | $1.92B | $1.36B | $1.00B | |
| Treasury Stock | $9.44B | $9.00B | $5.86B | $4.21B | $1.09B | $816M | $214M | $139M | $244M | $179M | $147M | $98M | |
| AOCI | $-58M | $-504M | $-652M | $-1.13B | $77M | $337M | $134M | $-56M | $-3M | $-36M | $-10M | $-1M | |
| Stockholders' Equity | $19.95B | $26.41B | $25.84B | $24.06B | $26.80B | $25.77B | $12.55B | $10.92B | $6.85B | $5.89B | $2.16B | $1.74B | |
| Liabilities + Equity | $76.75B | $82.44B | $84.64B | $76.87B | $78.38B | $68.72B | $40.99B | $30.90B | $21.86B | $20.20B | $7.34B | $5.82B | |
| Shares Outstanding | 491,757,000 | 620,195,000 | 615,291,000 | 607,847,000 | 602,704,000 | 598,249,000 | 421,508,000 | 417,695,000 | 360,758,000 | 356,268,000 | 253,710,000 | 124,275,000 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.27B | $1.24B | $1.29B | $1.43B | $1.33B | $1.26B | $643M | $495M | $361M | $278M | $111M | $89M | |
| Stock-based Comp | $204M | $212M | $216M | $234M | $203M | $281M | $177M | $145M | $135M | $148M | $71M | $48M | |
| Deferred Tax | $-60M | $13M | $-78M | $-631M | $-132M | $-51M | $55M | $-129M | $-108M | $92M | $-17M | $-42M | |
| Amort. of Intangibles | $685M | $692M | $718M | $817M | $770M | $719M | $258M | $211M | $156M | $147M | $24M | $16M | |
| Operating Cash Flow | $5.09B | $154M | $8.05B | $6.26B | $4.21B | $5.50B | $1.48B | $1.23B | $1.49B | $1.85B | $658M | $1.22B | |
| CapEx | $767M | $644M | $799M | $1.00B | $910M | $869M | $730M | $675M | $422M | $306M | $150M | $103M | |
| Investing Cash Flow | $472M | $-1.05B | $-1.19B | $-2.92B | $-3.30B | $-6.96B | $-1.53B | $-4.58B | $-1.25B | $-2.47B | $-813M | $-848M | |
| Debt Issued | $750M | $1.30B | $2.33B | $360M | $9.27B | $5.11B | $24.72B | $6.08B | $1.40B | $8.95B | $1.93B | $1.88B | |
| Net Debt Issued | $-1.15B | $678M | $19M | $-1.13B | $1.83B | $1.04B | $6.92B | $1.99B | $47M | $2.87B | $342M | $201M | |
| Stock Issued | $37M | $46M | $44M | $70M | $35M | $28M | $0 | $2.78B | $0 | $0 | · | · | |
| Stock Repurchased | $475M | $3.12B | $1.63B | $3.10B | $297M | $626M | $75M | $71M | $65M | $63M | $53M | $29M | |
| Net Stock Activity | $-438M | $-3.08B | $-1.59B | $-3.03B | $-297M | $-626M | $-75M | $2.71B | $-65M | $-63M | $-53M | $-29M | |
| Financing Cash Flow | $-1.62B | $-2.41B | $-1.66B | $-4.20B | $1.36B | $260M | $6.83B | $4.61B | $-82M | $2.72B | $305M | $198M | |
| Net Change in Cash | $3.94B | $-3.30B | $5.17B | $-868M | $2.26B | $-1.17B | $6.78B | $1.26B | $153M | $2.10B | $150M | $572M | |
| Taxes Paid | $448M | $1.00B | $887M | $1.20B | $678M | $1.19B | $612M | $448M | $496M | $556M | $328M | $237M | |
| Free Cash Flow | $4.32B | $-490M | $7.25B | $5.26B | $3.29B | $4.63B | $753M | $559M | $1.07B | $1.54B | $508M | $1.12B | |
| Levered FCF | · | · | $6.71B | $4.85B | $2.80B | $4.16B | $450M | $335M | $885M | $1.44B | $486M | $1.10B |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.3% | 10.5% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| Net Margin | -3.4% | 2.0% | 1.8% | 0.83% | 1.1% | 1.6% | 1.8% | 1.5% | 1.7% | 1.4% | 1.6% | 1.6% | |
| Pretax Margin | -3.5% | 2.6% | 2.3% | 1.4% | 1.4% | 2.5% | 2.4% | 2.3% | 2.3% | 2.9% | 3.1% | 2.8% | |
| EBITDA Margin | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% | 2.8% | 2.4% | 2.4% | 2.5% | 3.1% | 3.1% | 2.8% | |
| ROA | -8.4% | 4.0% | 3.4% | 1.6% | 1.8% | 3.3% | 3.7% | 3.4% | 3.9% | 4.1% | 5.4% | 5.8% | |
| ROE | -28.8% | 12.7% | 10.8% | 4.7% | 5.1% | 9.4% | 11.3% | 10.1% | 13.0% | 14.0% | 18.2% | 18.2% | |
| ROIC | -20.2% | 5.5% | 5.0% | 1.9% | 2.9% | 4.7% | 5.0% | 5.4% | 7.4% | 5.8% | 10.7% | 10.1% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.6 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 1.0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 1.1 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | |
| Interest Coverage | · | · | 4.0 | 2.0 | 2.7 | 4.2 | 4.3 | 4.3 | 4.7 | 5.8 | 16.4 | 13.3 |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.4 | 2.0 | 1.9 | 1.9 | 1.7 | 2.0 | 2.1 | 2.3 | 2.3 | 2.9 | 3.5 | 3.5 |
Stopy Wzrostu 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.4% | 5.9% | 6.5% | 14.7% | 13.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 27.5% | 139.1% | -9.2% | -26.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 40.4% | 16.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 22.3% | 124.8% | -10.8% | -25.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 34.9% | 14.3% | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B | $111.11B | $74.64B | $60.12B | $48.38B | $40.61B | $22.76B | $16.56B | |
| Net Income TTM | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B | $1.81B | $1.32B | $900M | $828M | $562M | $355M | $271M | |
| Market Cap | $20.24B | $30.04B | $39.66B | $45.17B | $48.00B | $34.91B | $26.09B | $23.78B | $8.75B | $4.86B | $3.96B | $3.07B | |
| Enterprise Value | $17.32B | $31.89B | $37.84B | $48.79B | $52.18B | $39.31B | $26.83B | $24.40B | $8.84B | $5.08B | $3.24B | $2.24B | |
| P/E | -3.0 | 9.6 | 15.0 | 39.6 | 36.1 | 19.2 | 20.0 | 25.5 | 21.6 | 16.5 | 11.4 | 11.5 | |
| P/S | 0.1 | 0.2 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | 0.2 | 0.1 | 0.2 | 0.2 | |
| P/B | 1.0 | 1.1 | 1.5 | 1.9 | 1.8 | 1.4 | 2.1 | 2.2 | 1.3 | 0.8 | 1.8 | 1.8 | |
| P / Tangible Book | 4.4 | 8.7 | 18.2 | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 4.0 | 195.1 | 4.9 | 7.2 | 11.4 | 6.3 | 17.6 | 19.3 | 5.9 | 2.6 | 6.0 | 2.5 | |
| P / FCF | 4.7 | -61.3 | 5.5 | 8.6 | 14.6 | 7.5 | 34.7 | 42.5 | 8.2 | 3.1 | 7.8 | 2.7 | |
| EV / EBITDA | -2.3 | 10.0 | 12.9 | 37.0 | 29.2 | 12.8 | 15.1 | 16.7 | 7.4 | 4.0 | 4.6 | 4.8 | |
| EV / FCF | 4.0 | -65.1 | 5.2 | 9.3 | 15.8 | 8.5 | 35.6 | 43.7 | 8.3 | 3.3 | 6.4 | 2.0 | |
| EV / Revenue | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Earnings Yield | -32.9% | 10.4% | 6.7% | 2.5% | 2.8% | 5.2% | 5.0% | 3.9% | 4.6% | 6.0% | 8.8% | 8.7% |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.58B | $49.94B | $49.73B | $49.69B | $48.74B | $46.62B | $40.80B | $42.02B | $39.84B | $40.41B | $39.46B | $38.04B | $37.61B | $38.89B | $35.56B | $35.87B | |
| Cost of Revenue | $729M | $702M | $680M | $651M | $641M | $698M | $688M | $692M | $680M | $669M | $961M | $856M | $877M | $870M | $1.37B | $1.57B | |
| Gross Profit | $4.62B | $5.65B | $2.56B | $3.35B | $3.02B | $5.29B | $3.80B | $4.01B | $4.53B | $4.74B | $3.74B | $4.63B | $4.61B | $4.65B | $3.91B | $4.04B | |
| SG&A Expense | $3.10B | $3.40B | $3.37B | $3.15B | $3.04B | $3.35B | $3.23B | $3.06B | $2.89B | $3.22B | $3.49B | $3.05B | $3.02B | $3.01B | $3.20B | $2.85B | |
| Operating Expenses | $52.38B | $48.08B | $51.47B | $56.64B | $49.20B | $45.09B | $40.63B | $41.36B | $38.61B | $39.30B | $39.65B | $37.31B | $36.44B | $37.67B | $35.84B | $35.39B | |
| Operating Income | $1.20B | $1.86B | $-1.75B | $-6.95B | $-458M | $1.53B | $175M | $665M | $1.23B | $1.11B | $-194M | $735M | $1.17B | $1.22B | $-282M | $476M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $178M | · | $181M | $181M | $180M | · | $169M | |
| Other Non-op | $288M | $238M | $202M | $280M | $201M | $212M | $172M | $256M | $287M | $367M | · | · | · | · | · | · | |
| Pretax Income | $1.49B | $2.10B | $-1.54B | $-6.67B | $-257M | $1.75B | $347M | $921M | $1.52B | $1.47B | $24M | $768M | $1.42B | $1.39B | $41M | $1.01B | |
| Income Tax | $399M | $560M | $-443M | $-42M | $2M | $432M | $67M | $211M | $370M | $315M | $-15M | $293M | $360M | $261M | $260M | $269M | |
| Net Income | $1.09B | $1.54B | $-1.10B | $-6.63B | $-253M | $1.31B | $283M | $713M | $1.15B | $1.16B | $45M | $469M | $1.06B | $1.13B | $-213M | $738M | |
| EPS (Basic) | $2.21 | $3.13 | $-2.16 | $-13.50 | $-0.51 | $2.64 | $0.63 | $1.37 | $2.16 | $2.17 | $0.12 | $0.87 | $1.93 | $2.05 | $-0.37 | $1.29 | |
| EPS (Diluted) | $2.19 | $3.11 | $-2.15 | $-13.50 | $-0.51 | $2.63 | $0.63 | $1.36 | $2.16 | $2.16 | $0.12 | $0.87 | $1.92 | $2.04 | $-0.35 | $1.27 | |
| Shares (Basic) | 493,819,000 | 492,069,000 | -987,787,000 | 491,141,000 | 493,548,000 | 496,214,000 | -1,064,886,000 | 521,965,000 | 529,602,000 | 535,109,000 | -1,095,927,000 | 539,535,000 | 548,932,000 | 550,779,000 | -1,165,644,000 | 573,961,000 | |
| Shares (Diluted) | 497,637,000 | 495,591,000 | -989,753,000 | 491,141,000 | 493,548,000 | 498,180,000 | -1,068,613,000 | 523,542,000 | 530,755,000 | 538,060,000 | -1,099,719,000 | 541,270,000 | 550,308,000 | 553,845,000 | -1,172,869,000 | 580,607,000 | |
| EBITDA | $1.20B | $1.86B | · | $-6.95B | $-458M | $1.53B | · | $665M | $1.23B | $1.11B | · | $735M | $1.17B | $1.22B | · | $476M |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.15B | $21.26B | $17.89B | $17.06B | $14.51B | $14.81B | $14.06B | $14.58B | $17.61B | $17.59B | $17.19B | $18.19B | $17.17B | $15.85B | $12.07B | $14.99B | |
| Short-term Investments | $2.91B | $2.48B | $2.43B | $2.18B | $2.77B | $2.47B | $2.62B | $2.99B | $2.61B | $2.08B | · | $2.24B | $2.21B | $2.13B | · | $2.19B | |
| Other Current Assets | $1.55B | $1.82B | $1.95B | $1.72B | $1.56B | $1.56B | $1.60B | $1.56B | $1.60B | $1.96B | · | $5.47B | $1.88B | $1.81B | · | $2.33B | |
| Current Assets | $46.69B | $44.99B | $40.37B | $44.06B | $40.39B | $41.29B | $38.00B | $37.41B | $38.41B | $38.45B | · | $41.41B | $34.87B | $35.01B | · | $33.27B | |
| PP&E (Net) | $2.13B | $2.09B | $2.04B | $2.16B | $2.12B | $2.04B | $2.07B | $2.04B | $2.04B | $1.99B | · | $2.00B | $2.42B | $2.48B | · | $2.48B | |
| PP&E (Gross) | · | · | $4.27B | · | · | · | $4.87B | · | · | · | · | · | · | · | · | $4.54B | |
| Accum. Depreciation | · | · | $2.23B | · | · | · | $2.80B | · | · | · | · | · | · | · | · | $2.06B | |
| Goodwill | $10.84B | $10.84B | $10.84B | $10.84B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $17.56B | $18.72B | $18.84B | $18.81B | $20.04B | |
| Intangibles | $4.20B | $4.36B | $4.53B | $4.84B | $5.01B | $5.24B | $5.41B | $5.58B | $5.75B | $5.93B | · | $6.28B | $6.52B | $6.73B | · | $7.52B | |
| Other Non-current Assets | $1.37B | $866M | $528M | $593M | $1.11B | $1.24B | $593M | $617M | $1.09B | $823M | · | $560M | $2.87B | $2.78B | · | $2.60B | |
| Total Assets | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Accounts Payable | $17.96B | $16.83B | $13.77B | $16.88B | $13.52B | $13.95B | $13.17B | $13.34B | $12.23B | $12.13B | · | $15.08B | $9.87B | $10.78B | · | $9.99B | |
| Current Liabilities | $40.76B | $40.05B | $36.70B | $40.63B | $36.79B | $37.14B | $34.26B | $34.06B | $32.73B | $32.78B | · | $36.85B | $31.31B | $32.86B | · | $31.33B | |
| Capital Leases | · | · | $615M | · | · | · | $738M | · | · | · | · | $936M | $3.17B | $3.14B | · | $3.04B | |
| Deferred Tax | $756M | $744M | $833M | $810M | $651M | $708M | $684M | $769M | $665M | $734M | · | $577M | $495M | $522M | · | $480M | |
| Other Non-current Liabilities | $2.81B | $2.55B | $1.81B | $2.05B | $3.90B | $2.87B | $2.57B | $2.62B | $4.77B | $4.16B | · | $3.65B | $7.37B | $6.19B | · | $5.68B | |
| Total Liabilities | $60.35B | $59.65B | $56.69B | $61.03B | $58.89B | $59.02B | $55.94B | $54.94B | $55.68B | $55.56B | · | $58.97B | $57.07B | $57.80B | · | $55.57B | |
| Long-term Debt | $16.11B | $16.37B | $17.49B | $17.58B | $17.58B | $18.32B | $18.53B | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Total Debt | $16.11B | $16.37B | · | $17.58B | $17.58B | $18.32B | · | $17.61B | $17.63B | $18.00B | · | $18.00B | $18.01B | $18.32B | · | $18.33B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $11.31B | $10.21B | $8.67B | $9.78B | $16.41B | $16.66B | $15.35B | $15.06B | $14.35B | $13.21B | · | $12.00B | $11.53B | $10.47B | · | $9.55B | |
| Treasury Stock | $9.44B | $9.44B | $9.44B | $9.44B | $9.44B | $9.04B | $9.00B | $8.05B | $6.82B | $6.01B | · | $5.83B | $5.04B | $4.64B | · | $2.56B | |
| AOCI | $-194M | $-171M | $-58M | $-100M | $-231M | $-337M | $-504M | $-226M | $-646M | $-630M | · | $-1.12B | $-998M | $-915M | · | $-1.39B | |
| Stockholders' Equity | $22.56B | $21.43B | $19.95B | $20.95B | $27.41B | $27.92B | $26.41B | $27.31B | $27.35B | $26.96B | · | $25.30B | $25.67B | $25.04B | · | $25.38B | |
| Liabilities + Equity | $83.01B | $81.17B | $76.75B | $82.09B | $86.39B | $87.04B | $82.44B | $82.35B | $83.14B | $82.62B | · | $84.38B | $82.85B | $82.98B | · | $81.17B | |
| Shares Outstanding | 493,987,000 | 493,771,000 | 491,757,000 | 491,414,000 | 491,128,000 | 497,518,000 | 495,907,000 | 510,078,000 | 526,001,000 | 536,383,000 | 615,291,000 | 534,596,000 | 546,003,000 | 551,714,000 | 607,847,000 | 570,091,000 |
Przepływy pieniężne 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $300M | $300M | $329M | $317M | $315M | $314M | $314M | $313M | $306M | $308M | $315M | $328M | $304M | $325M | $351M | $292M | |
| Stock-based Comp | $59M | $67M | $58M | $52M | $35M | $59M | $31M | $49M | $62M | $70M | $49M | $50M | $56M | $61M | $54M | $51M | |
| Deferred Tax | $19M | $-53M | $-73M | $129M | $-89M | $-27M | $-1M | $-26M | $-64M | $104M | $-92M | $174M | $-1M | $-159M | $51M | $-265M | |
| Amort. of Intangibles | $161M | $166M | $169M | $170M | $173M | $173M | $173M | $173M | $173M | $173M | $176M | $180M | $179M | $183M | $208M | $211M | |
| Operating Cash Flow | $3.59B | $4.37B | $437M | $1.36B | $1.78B | $1.51B | $-587M | $-978M | $2.17B | $-456M | $217M | $1.02B | $2.55B | $4.27B | $-1.58B | $3.33B | |
| CapEx | $174M | $200M | $213M | $211M | $208M | $135M | $154M | $153M | $186M | $151M | $223M | $136M | $215M | $225M | $233M | $247M | |
| Investing Cash Flow | $-353M | $89M | $660M | $1.24B | $-899M | $-529M | $102M | $-839M | $-1.17B | $852M | $-949M | $435M | $-424M | $-253M | $221M | $3M | |
| Debt Issued | $0 | $0 | $0 | $0 | $0 | $750M | $950M | $0 | $0 | $350M | $165M | $889M | $994M | $287M | $3M | $26M | |
| Net Debt Issued | · | $-1.05B | · | · | · | $-208M | · | · | · | $163M | · | · | · | $287M | · | · | |
| Stock Issued | $8M | $10M | $8M | $11M | $8M | $10M | $9M | $12M | $11M | $14M | $12M | $11M | $21M | $12M | $8M | $24M | |
| Stock Repurchased | $4M | $29M | $2M | $0 | $432M | $41M | $943M | $1.23B | $803M | $151M | $31M | $774M | $405M | $423M | $1.43B | $1.24B | |
| Net Stock Activity | · | $-19M | · | · | · | $-31M | · | · | · | $-137M | · | · | · | $-423M | · | · | |
| Financing Cash Flow | $-259M | $-1.06B | $-187M | $-10M | $-1.17B | $-250M | $-13M | $-1.25B | $-1.17B | $23M | $-201M | $-524M | $-750M | $-183M | $-1.73B | $-1.48B | |
| Net Change in Cash | $2.98B | $3.39B | $910M | $2.59B | $-288M | $731M | $-497M | $-3.06B | $-162M | $425M | $-984M | $958M | $1.36B | $3.83B | $-3.06B | $1.83B | |
| Taxes Paid | $-206M | $-19M | $-92M | $36M | $497M | $7M | $181M | $211M | $538M | $13M | $128M | $167M | $581M | $11M | $750M | $37M | |
| Free Cash Flow | · | $4.17B | · | · | · | $1.38B | · | · | · | $-607M | · | · | · | $4.04B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-747M | · | · | · | $3.90B | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.6% | 11.3% | · | 6.7% | 6.2% | 11.3% | · | 9.5% | 11.4% | 11.7% | · | 12.2% | 12.3% | 11.9% | · | · | |
| Operating Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| Net Margin | 2.0% | 3.1% | · | -13.3% | -0.52% | 2.8% | · | 1.7% | 2.9% | 2.9% | · | 1.2% | 2.8% | 2.9% | · | 2.1% | |
| Pretax Margin | 2.8% | 4.2% | · | -13.4% | -0.53% | 3.8% | · | 2.2% | 3.8% | 3.6% | · | 2.0% | 3.8% | 3.6% | · | 2.8% | |
| EBITDA Margin | 2.2% | 3.7% | · | -14.0% | -0.94% | 3.3% | · | 1.6% | 3.1% | 2.7% | · | 1.9% | 3.1% | 3.1% | · | 1.3% | |
| ROA | 1.3% | 1.8% | · | -8.1% | -0.30% | 1.6% | · | 0.86% | 1.4% | 1.4% | · | 0.57% | 1.3% | 1.4% | · | 0.93% | |
| ROE | 4.4% | 6.2% | · | -27.5% | -0.92% | 4.8% | · | 2.7% | 4.3% | 4.5% | · | 1.8% | 4.1% | 4.3% | · | 2.9% | |
| ROIC | 2.3% | 3.6% | · | -17.9% | -1.0% | 2.5% | · | 1.1% | 2.1% | 1.9% | · | 1.1% | 2.0% | 2.3% | · | 0.80% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | |
| Quick Ratio | 0.7 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.8 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 6.2 | · | 4.1 | 6.5 | 6.8 | · | 2.8 |
Efektywność 1
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $201.96B | $195.00B | · | $187.07B | $177.22B | $168.89B | · | $160.31B | $155.89B | $154.95B | · | $150.40B | $148.30B | $147.88B | · | $141.39B | |
| Net Income TTM | $-4.25B | $-4.03B | · | $-4.86B | $2.92B | $4.33B | · | $3.49B | $3.84B | $3.82B | · | $3.40B | $2.75B | $2.54B | · | $2.00B | |
| Market Cap | $31.71B | $16.17B | · | $17.53B | $26.66B | $30.20B | · | $38.40B | $34.87B | $42.10B | · | $36.82B | $36.83B | $34.87B | · | $44.36B | |
| Enterprise Value | $20.76B | $8.80B | · | $15.88B | $26.95B | $31.24B | · | $38.43B | $32.29B | $40.43B | · | $34.39B | $35.45B | $35.21B | · | $45.51B | |
| P/E | -7.4 | -4.0 | · | -3.6 | 9.6 | 7.3 | · | 11.5 | 9.3 | 11.2 | · | 11.3 | 13.7 | 14.2 | · | 22.8 | |
| P/S | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| P/B | 1.4 | 0.8 | · | 0.8 | 1.0 | 1.1 | · | 1.4 | 1.3 | 1.6 | · | 1.5 | 1.4 | 1.4 | · | 1.7 | |
| P / Tangible Book | 4.2 | 2.6 | · | 3.3 | 5.5 | 5.9 | · | 9.2 | 8.6 | 12.1 | · | 25.2 | 84.7 | · | · | · | |
| P / Cash Flow | · | 3.7 | · | · | · | 20.0 | · | · | · | -92.3 | · | · | · | 8.2 | · | · | |
| P / FCF | · | 3.9 | · | · | · | 22.0 | · | · | · | -69.3 | · | · | · | 8.6 | · | · | |
| EV / EBITDA | 17.3 | 4.7 | · | -2.3 | -58.9 | 20.4 | · | 57.8 | 26.3 | 36.6 | · | 46.8 | 30.3 | 28.9 | · | 95.6 | |
| EV / FCF | · | 2.1 | · | · | · | 22.7 | · | · | · | -66.6 | · | · | · | 8.7 | · | · | |
| EV / Revenue | 0.1 | 0.0 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Earnings Yield | -13.6% | -25.3% | · | -28.1% | 10.4% | 13.7% | · | 8.7% | 10.7% | 8.9% | · | 8.9% | 7.3% | 7.1% | · | 4.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B |
| Marża Brutto % | 7.3% | 10.5% | 11.5% | — | — |
| Marża Operacyjna % | -3.9% | 1.9% | 1.9% | 0.91% | 1.4% |
| Zysk netto | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| Rozwodniony EPS | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 |
| Wskaźnik bieżący | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| Wskaźnik Szybkości | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $4.32B | $-490M | $7.25B | $5.26B | $3.29B |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 1 120 emitentów · $20.6B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 235 (+120 vs poprzedni kw.) | 74 (-55 vs poprzedni kw.) | 345 (+50 vs poprzedni kw.) | 323 (-35 vs poprzedni kw.) | +79.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2 020 581 807 | 31 478 140 | 9,81% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 434 820 070 | 22 352 704 | 6,96% | Akcje |
| STATE STREET CORP | $1 409 957 100 | 21 965 370 | 6,84% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $836 741 748 | 13 035 391 | 4,06% | Akcje |
| AMERIPRISE FINANCIAL INC | $788 928 731 | 12 277 112 | 3,83% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $754 901 345 | 11 765 825 | 3,66% | Akcje |
| HARRIS ASSOCIATES L P | $714 090 642 | 11 124 640 | 3,47% | Akcje |
| NORGES BANK | $491 166 346 | 7 651 758 | 2,38% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $478 360 377 | 7 452 257 | 2,32% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $407 480 559 | 6 348 038 | 1,98% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $366 680 625 | 5 712 426 | 1,78% | Akcje |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $314 595 190 | 4 901 000 | 1,53% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $290 158 057 | 4 520 300 | 1,41% | Opcja kupna |
| Assenagon Asset Management S.A. | $238 531 902 | 3 716 029 | 1,16% | Akcje |
| EARNEST PARTNERS LLC | $227 030 787 | 3 536 856 | 1,10% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $219 279 973 | 3 416 108 | 1,06% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $197 821 063 | 3 081 805 | 0,96% | Akcje |
| 8 KNOTS MANAGEMENT, LLC | $193 662 188 | 4 706 250 | 0,94% | Akcje |
| Robeco Institutional Asset Management B.V. | $176 439 634 | 2 748 709 | 0,86% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $170 815 325 | 2 661 089 | 0,83% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $170 810 874 | 2 661 020 | 0,83% | Akcje |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $164 395 918 | 2 561 083 | 0,80% | Akcje |
| JANE STREET GROUP, LLC | $161 149 958 | 2 510 515 | 0,78% | Akcje |
| LYRICAL ASSET MANAGEMENT LP | $157 262 740 | 2 449 957 | 0,76% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $156 896 112 | 2 444 246 | 0,76% | Akcje |
| JANE STREET GROUP, LLC | $150 243 114 | 2 340 600 | 0,73% | Opcja kupna |
| RENAISSANCE TECHNOLOGIES LLC | $140 730 926 | 2 192 412 | 0,68% | Akcje |
| Politan Capital Management LP | $137 059 130 | 2 135 210 | 0,67% | Akcje |
| CITADEL ADVISORS LLC | $135 787 526 | 2 115 400 | 0,66% | Opcja kupna |
| Qube Research & Technologies Ltd | $131 408 741 | 2 047 184 | 0,64% | Akcje |
| Quantinno Capital Management LP | $126 343 727 | 1 968 277 | 0,61% | Akcje |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $121 065 870 | 1 886 055 | 0,59% | Akcje |
| Scharf Investments, LLC | $105 948 709 | 1 650 542 | 0,51% | Akcje |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $104 240 580 | 1 623 938 | 0,51% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $102 119 807 | 1 590 899 | 0,50% | Akcje |
| Ninety One UK Ltd | $97 040 208 | 1 511 766 | 0,47% | Akcje |
| BlackRock, Inc. | $96 995 070 | 1 511 062 | 0,47% | Akcje |
| IEQ CAPITAL, LLC | $94 667 113 | 1 474 796 | 0,46% | Akcje |
| Long Focus Capital Management, LLC | $93 075 500 | 1 450 000 | 0,45% | Akcje |
| Caisse de depot et placement du Quebec | $90 440 436 | 1 408 949 | 0,44% | Akcje |
| TWO SIGMA ADVISERS, LP | $90 393 876 | 2 196 692 | 0,44% | Akcje |
| Walleye Trading LLC | $89 769 715 | 1 398 500 | 0,44% | Opcja kupna |
| Swiss National Bank | $89 039 490 | 1 387 124 | 0,43% | Akcje |
| Maple Rock Capital Partners Inc. | $88 702 813 | 1 381 879 | 0,43% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $88 037 805 | 1 371 519 | 0,43% | Akcje |
| Capital World Investors | $85 968 319 | 1 339 279 | 0,42% | Akcje |
| ROYAL BANK OF CANADA | $83 731 000 | 1 304 424 | 0,41% | Akcje |
| FMR LLC | $82 642 699 | 1 287 470 | 0,40% | Akcje |
| Legal & General Group Plc | $82 580 180 | 1 286 496 | 0,40% | Akcje |
| GOLDMAN SACHS GROUP INC | $81 658 346 | 1 272 135 | 0,40% | Akcje |
| Swedbank AB | $81 278 855 | 1 266 223 | 0,39% | Akcje |
| BANK OF AMERICA CORP /DE/ | $81 231 546 | 1 265 486 | 0,39% | Akcje |
| BANK OF MONTREAL /CAN/ | $75 731 362 | 1 179 800 | 0,37% | Opcja sprzedaży |
| Mitsubishi UFJ Asset Management Co., Ltd. | $74 883 027 | 1 166 584 | 0,36% | Akcje |
| Focused Investors LLC | $71 748 372 | 1 117 750 | 0,35% | Akcje |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $69 539 402 | 1 083 337 | 0,34% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $69 328 795 | 1 080 056 | 0,34% | Akcje |
| Vanguard Global Advisers, LLC | $67 731 876 | 1 055 178 | 0,33% | Akcje |
| CAXTON ASSOCIATES LP | $66 708 455 | 1 101 163 | 0,32% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $65 768 946 | 1 024 598 | 0,32% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65 005 213 | 1 012 700 | 0,32% | Opcja sprzedaży |
| RHUMBLINE ADVISERS | $64 689 517 | 1 007 784 | 0,31% | Akcje |
| Korea Investment CORP | $64 394 509 | 1 003 186 | 0,31% | Akcje |
| Walleye Trading LLC | $63 084 520 | 982 778 | 0,31% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $61 600 511 | 959 659 | 0,30% | Akcje |
| National Pension Service | $60 317 674 | 939 674 | 0,29% | Akcje |
| JANE STREET GROUP, LLC | $58 470 671 | 910 900 | 0,28% | Opcja sprzedaży |
| CITADEL ADVISORS LLC | $57 584 849 | 897 100 | 0,28% | Opcja sprzedaży |
| Vinva Investment Management Ltd | $57 411 190 | 885 450 | 0,28% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $54 527 351 | 849 468 | 0,26% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $53 459 229 | 832 828 | 0,26% | Akcje |
| BANK OF NOVA SCOTIA | $53 046 262 | 826 395 | 0,26% | Akcje |
| California Public Employees Retirement System | $52 789 535 | 822 395 | 0,26% | Akcje |
| Gotham Asset Management, LLC | $51 174 579 | 797 236 | 0,25% | Akcje |
| Pine Valley Investments Ltd Liability Co | $49 047 579 | 764 100 | 0,24% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $48 416 284 | 754 265 | 0,23% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $46 947 683 | 730 827 | 0,23% | Akcje |
| Cresset Asset Management, LLC | $46 069 740 | 717 709 | 0,22% | Akcje |
| Walleye Trading LLC | $45 581 319 | 710 100 | 0,22% | Opcja sprzedaży |
| PRUDENTIAL FINANCIAL INC | $44 480 846 | 692 956 | 0,22% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $44 054 239 | 686 310 | 0,21% | Akcje |
| Point72 Asset Management, L.P. | $43 807 685 | 682 469 | 0,21% | Akcje |
| CAMBIAR INVESTORS LLC | $43 472 742 | 677 251 | 0,21% | Akcje |
| Kopernik Global Investors, LLC | $41 512 700 | 646 716 | 0,20% | Akcje |
| D. E. Shaw & Co., Inc. | $41 248 494 | 642 600 | 0,20% | Opcja sprzedaży |
| BARCLAYS PLC | $40 106 039 | 624 802 | 0,19% | Akcje |
| Alberta Investment Management Corp | $38 514 000 | 600 000 | 0,19% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $37 494 278 | 584 114 | 0,18% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $37 459 914 | 618 349 | 0,18% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $36 941 345 | 575 500 | 0,18% | Opcja kupna |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $36 392 328 | 566 947 | 0,18% | Akcje |
| Pictet Asset Management Holding SA | $35 261 300 | 549 327 | 0,17% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $33 902 270 | 528 155 | 0,16% | Akcje |
| VANGUARD GROUP INC | $33 224 057 | 807 389 | 0,16% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $30 879 877 | 943 185 | 0,15% | Akcje |
| MACKENZIE FINANCIAL CORP | $30 726 084 | 478 674 | 0,15% | Akcje |
| IMC-Chicago, LLC | $30 548 920 | 475 914 | 0,15% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $30 455 395 | 474 457 | 0,15% | Akcje |
| Polar Capital Holdings Plc | $30 274 251 | 471 635 | 0,15% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $29 598 153 | 450 299 | 0,14% | Akcje |
Insiderzy spółki 77 insiderów · 48 dyrektorzy generalni · 30 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Sarah London | Chief Executive Officer | 15 marca 2026 F | 1 188 831 | 0 | 0 | $0 |
| David P Thomas | CEO, Markets and Medicaid | 15 grudnia 2023 F | 132 941 | 0 | 0 | $0 |
| NEIDORFF MICHAEL F | Chairman & CEO | 15 grudnia 2021 A | 6 517 610 | 0 | 0 | $0 |
| Andrew Lynn Asher | Chief Financial Officer | 15 marca 2026 F | 747 989 | 0 | 0 | $0 |
| William Scheffel | Exec VP, CFO & Treasurer | 1 marca 2016 F | 138 362 | 0 | 0 | $0 |
| Michael A Carson | Group President, Medicare&Spec | 29 maja 2026 I | — | 0 | 0 | $0 |
| Kenneth J Fasola | President | 4 lipca 2024 F | 286 066 | 0 | 0 | $0 |
| Susan Raye Smith | Chief Operating Officer | 15 czerwca 2026 F | 212 237 | 0 | 0 | $0 |
| James E Murray | EVP, Chief Operating Officer | 23 czerwca 2023 A | 202 853 | 0 | 0 | $0 |
| Tanya M Mcnally | Chief People Officer | 15 kwietnia 2026 F | 127 258 | 0 | 0 | $0 |
| Katie Casso | Corporate Controller & CAO | 15 marca 2026 F | 109 776 | 0 | 0 | $0 |
| Christopher Koster | Secretary & General Counsel | 15 marca 2026 F | 352 836 | 0 | 0 | $0 |
| Colin A Toney | EVP, Mergers & Acquisitions | 16 września 2022 A | 52 123 | 0 | 0 | $0 |
| Mark J Brooks | EVP, Chief Information Officer | 16 września 2022 A | 153 755 | 0 | 0 | $0 |
| Shannon Bagley | EVP, Chief Admin. Officer | 16 sierpnia 2022 F | 116 705 | 0 | 0 | $0 |
| Brandy Burkhalter | EVP | 24 marca 2022 F | 350 475 | 0 | 0 | $0 |
| Jesse N Hunter | EVP, M&A & Chief Strategy Ofcr | 11 czerwca 2021 S | 411 792 | 0 | 0 | $0 |
| Jeffrey A. Schwaneke | EVP, HealthCare Enterprises | 7 maja 2021 S | 454 549 | 0 | 0 | $0 |
| Christopher R Isaak | SVP, Corporate Controller, CAO | 15 grudnia 2020 F | 13 630 | 0 | 0 | $0 |
| Keith H Williamson | EVP, Secr. & General Counsel | 4 lutego 2020 F | 174 049 | 0 | 0 | $0 |
| Christopher D Bowers | EVP, Markets | 22 lipca 2019 A | 131 492 | 0 | 0 | $0 |
| Cynthia J Brinkley | EVP, Chief Admin/Markets Offcr | 5 lutego 2019 F | 300 582 | 0 | 0 | $0 |
| Kenneth Rone Baldwin | EVP, Markets | 15 grudnia 2016 F | 92 712 | 0 | 0 | $0 |
| Carol Goldman | Exec VP Chief Admin Officer | 15 grudnia 2016 F | 70 876 | 0 | 0 | $0 |
| Donald G Imholz | EVP, Operations and CIO | 11 grudnia 2015 G | 151 599 | 0 | 0 | $0 |
| David C Minifie | CMO, EVP Corporate Strategy | 3 lutego 2015 F | 24 031 | 0 | 0 | $0 |
| Robert T Hitchcock | EVP Health Plans | 3 lutego 2015 F | 26 415 | 0 | 0 | $0 |
| Edmund E Kroll | SVP Fin & Investor Relations | 3 lutego 2015 F | 46 279 | 0 | 0 | $0 |
| HARROLD JASON M | EVP, Specialty Comp. Bus. Unit | 3 lutego 2015 F | 44 329 | 0 | 0 | $0 |
| Karen Bedell | SVP Business Liaison | 14 grudnia 2012 F | 46 819 | 0 | 0 | $0 |
| Mary V Mason | SVP & Chief Medical Officer | 14 grudnia 2012 F | 38 974 | 0 | 0 | $0 |
| Mark W Eggert | Executive VP, Health Plans | 14 lutego 2012 M | 103 712 | 0 | 0 | $0 |
| Antonette Simonetti | SVP, Public Affairs | 14 grudnia 2010 F | 13 377 | 0 | 0 | $0 |
| Frederick J Manning | Executive Vice President | 14 grudnia 2010 F | 20 579 | 0 | 0 | $0 |
| Cary Hobbs | SVP, Bus Mgmt & Integration | 16 grudnia 2009 M | 20 768 | 0 | 0 | $0 |
| Eric Slusser | Executive VP of Internat'l Dev | 16 października 2009 A | 51 754 | 0 | 0 | $0 |
| Patti Darnley | Sr. VP of Operations | 14 grudnia 2007 A | 14 188 | 0 | 0 | $0 |
| Marie J Glancy | SVP, Oper Svcs & Reg Affairs | 14 grudnia 2007 A | 12 362 | 0 | 0 | $0 |
| Per J Brodin | SVP, Chief Acctg Officer | 12 grudnia 2007 A | 13 337 | 0 | 0 | $0 |
| Glendon A Schuster | Senior VP and CIO | 12 grudnia 2006 A | — | 0 | 0 | $0 |
| Lisa M Wilson | Sr. VP Investor Relations | 12 grudnia 2006 A | 18 400 | 0 | 0 | $0 |
| Karey L Witty | SVP, Health Plan Business Unit | 12 grudnia 2006 A | 57 500 | 0 | 0 | $0 |
| Joseph P Drozda JR | Sr. VP & Chief Medical Officer | 12 grudnia 2006 A | 32 181 | 0 | 0 | $0 |
| James D Donovan JR | Senior VP Health Plans | 13 grudnia 2005 A | 3 219 | 0 | 0 | $0 |
| Brian G Spanel | Sr Vice President, Development | 24 czerwca 2005 M | 186 446 | 0 | 0 | $0 |
| Dan Paquin | Sr. VP New Plan Implementation | 10 lutego 2005 M | 0 | 0 | 0 | $0 |
| John Tadich | Senior VP, Specialty Companies | 1 grudnia 2004 M | 0 | 0 | 0 | $0 |
| Catherine M Halverson | Senior VP Business Development | 16 stycznia 2004 | 0 | 0 | 0 | $0 |
| Paul J Diaz | Dyrektor | 28 lipca 2026 A | 2 771 | 0 | 0 | $0 |
| Lauren M Tyler | Dyrektor | 17 lipca 2026 A | 3 216 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 186 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHF · iShares Trust | 4,19% | 807 594 SH | 8 sierpnia 2026 | Dziennie |
| CAMX · ADVISORS' INNER CIRCLE FUND | 3,57% | 44 000 NS | 30 kwietnia 2026 | N-PORT |
| SMRI · EA Series Trust | 3,05% | 307 327 NS | 30 kwietnia 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2,65% | 686 794 SH | 8 sierpnia 2026 | Dziennie |
| SRHQ · Elevation Series Trust | 1,96% | 70 588 NS | 30 kwietnia 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1,93% | 87 905 NS | 31 marca 2026 | N-PORT |
| RUNN · Strategic Trust | 1,87% | 108 380 NS | 31 maja 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,82% | 68 233 SH | 8 sierpnia 2026 | Dziennie |
| KAT · Advisors Series Trust | 1,68% | 345 595 NS | 31 marca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,52% | 181 368 SH | 8 sierpnia 2026 | Dziennie |
| EPMB · Harbor ETF Trust | 1,51% | 1 264 NS | 30 kwietnia 2026 | N-PORT |
| EPMV · Harbor ETF Trust | 1,40% | 1 157 NS | 30 kwietnia 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,32% | 2 739 NS | 30 kwietnia 2026 | N-PORT |
| EPSB · Harbor ETF Trust | 1,29% | 1 122 NS | 30 kwietnia 2026 | N-PORT |
| ABCS · EA Series Trust | 1,12% | 2 127 NS | 29 maja 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 1,04% | 30 046 000 | 8 sierpnia 2026 | Dziennie |
| AVMV · AMERICAN CENTURY ETF TRUST | 1,01% | 105 126 NS | 31 maja 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,97% | 1 475 110 SH | 8 sierpnia 2026 | Dziennie |
| RILA · Spinnaker ETF Series | 0,92% | 7 203 NS | 30 kwietnia 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,75% | 856 NS | 31 maja 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,75% | 22 285 000 | 8 sierpnia 2026 | Dziennie |
| WLDR · Two Roads Shared Trust | 0,74% | 9 894 NS | 30 kwietnia 2026 | N-PORT |
| ITAN · EA Series Trust | 0,66% | 9 949 NS | 29 maja 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0,65% | 149 910 SH | 8 sierpnia 2026 | Dziennie |
| CLSE · Trust for Professional Managers | 0,64% | 66 218 NS | 31 maja 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,63% | 90 872 NS | 30 kwietnia 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,62% | 139 637 NS | 30 kwietnia 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,53% | 3 779 NS | 30 kwietnia 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,52% | 1 263 251 NS | 31 maja 2026 | N-PORT |
| IYH · iShares Trust | 0,51% | 295 112 SH | 8 sierpnia 2026 | Dziennie |
| VLUE · iShares Trust | 0,51% | 742 494 SH | 8 sierpnia 2026 | Dziennie |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,48% | 18 134 000 | 8 sierpnia 2026 | Dziennie |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,48% | 1 515 000 PA | 8 sierpnia 2026 | Dziennie |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,48% | 819 NS | 31 maja 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,47% | 1 478 248 SH | 8 sierpnia 2026 | Dziennie |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,44% | 942 740 NS | 31 maja 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,43% | 62 007 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,43% | 226 652 NS | 30 kwietnia 2026 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0,43% | 1 819 403 NS | 31 maja 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0,41% | 173 542 NS | 30 kwietnia 2026 | N-PORT |
| RXL · ProShares Trust | 0,40% | 4 871 NS | 31 maja 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,40% | 611 391 SH | 8 sierpnia 2026 | Dziennie |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,40% | 27 252 NS | 31 maja 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,40% | 21 013 NS | 30 kwietnia 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,39% | 85 952 NS | 31 maja 2026 | N-PORT |
| ESMV · iShares Trust | 0,38% | 471 SH | 8 sierpnia 2026 | Dziennie |
| CGGO · Capital Group Global Growth Equity … | 0,38% | 728 871 NS | 31 maja 2026 | N-PORT |
| IXJ · iShares Trust | 0,38% | 246 114 SH | 8 sierpnia 2026 | Dziennie |
| COPY · RBB Fund Trust | 0,36% | 21 043 NS | 31 maja 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,36% | 9 315 NS | 30 kwietnia 2026 | N-PORT |